Alfred Sandrock - 07 Jun 2021 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Research & Development
Signature
/s/ Suzanne Murray, Attorney in Fact for Alfred W. Sandrock, Jr.
Issuer symbol
BIIB
Transactions as of
07 Jun 2021
Net transactions value
-$3,375,680
Form type
4
Filing time
09 Jun 2021, 19:05:57 UTC
Next filing
09 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Sale $3,375,680 -7,672 -43% $440.00 10,169 07 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021.